A literature revision in primary cutaneous B-cell lymphoma

R. La Selva; S. Alberti Violetti; C. Delfino; V. Grandi; S. Cicchelli; C. Tomasini; M. T. Fierro; E. Berti; N. Pimpinelli; P. Quaglino

doi:10.4103/ijd.IJD_74_17

A literature revision in primary cutaneous B-cell lymphoma

R. La Selva, S. Alberti Violetti, C. Delfino, V. Grandi, S. Cicchelli, C. Tomasini, M. T. Fierro, E. Berti, N. Pimpinelli, P. Quaglino

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Article › peer-review

Abstract

The term 'Primary Cutaneous B-Cell Lymphoma' (PCBCL) comprehends a variety of lymphoproliferative disorders characterized by a clonal proliferation of B-cells primarily involving the skin. The absence of evident extra-cutaneous disease must be confirmed after six-month follow-up in order to exclude a nodal non-Hodgkin's lymphoma (NHL) with secondary cutaneous involvement, which may have a completely different clinical behavior and prognosis. In this article, we have summarized the clinico-pathological features of main types of PCBCL and we outline the guidelines for management based on a review of the available literature.

Original language	English
Pages (from-to)	146-157
Number of pages	12
Journal	Indian Journal of Dermatology
Volume	62
Issue number	2
DOIs	https://doi.org/10.4103/ijd.IJD_74_17
Publication status	Published - Mar 1 2017

Keywords

Cutaneous B-cell lymphoma
Primary Cutaneous Diffuse Large B cell Lymphoma other
Primary cutaneous diffuse large B-cell lymphoma leg type
Primary cutaneous follicle-center lymphoma
Primary Cutaneous Marginal zone Lymphoma

ASJC Scopus subject areas

Dermatology

Access to Document

10.4103/ijd.IJD_74_17

Cite this

@article{3d87193000c2416b888e595741b3d183,

title = "A literature revision in primary cutaneous B-cell lymphoma",

abstract = "The term 'Primary Cutaneous B-Cell Lymphoma' (PCBCL) comprehends a variety of lymphoproliferative disorders characterized by a clonal proliferation of B-cells primarily involving the skin. The absence of evident extra-cutaneous disease must be confirmed after six-month follow-up in order to exclude a nodal non-Hodgkin's lymphoma (NHL) with secondary cutaneous involvement, which may have a completely different clinical behavior and prognosis. In this article, we have summarized the clinico-pathological features of main types of PCBCL and we outline the guidelines for management based on a review of the available literature.",

keywords = "Cutaneous B-cell lymphoma, Primary Cutaneous Diffuse Large B cell Lymphoma other, Primary cutaneous diffuse large B-cell lymphoma leg type, Primary cutaneous follicle-center lymphoma, Primary Cutaneous Marginal zone Lymphoma",

author = "{La Selva}, R. and {Alberti Violetti}, S. and C. Delfino and V. Grandi and S. Cicchelli and C. Tomasini and Fierro, {M. T.} and E. Berti and N. Pimpinelli and P. Quaglino",

year = "2017",

month = mar,

day = "1",

doi = "10.4103/ijd.IJD_74_17",

language = "English",

volume = "62",

pages = "146--157",

journal = "Indian Journal of Dermatology",

issn = "0019-5154",

publisher = "Medknow Publications and Media Pvt. Ltd",

number = "2",

}

TY - JOUR

T1 - A literature revision in primary cutaneous B-cell lymphoma

AU - La Selva, R.

AU - Alberti Violetti, S.

AU - Delfino, C.

AU - Grandi, V.

AU - Cicchelli, S.

AU - Tomasini, C.

AU - Fierro, M. T.

AU - Berti, E.

AU - Pimpinelli, N.

AU - Quaglino, P.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - The term 'Primary Cutaneous B-Cell Lymphoma' (PCBCL) comprehends a variety of lymphoproliferative disorders characterized by a clonal proliferation of B-cells primarily involving the skin. The absence of evident extra-cutaneous disease must be confirmed after six-month follow-up in order to exclude a nodal non-Hodgkin's lymphoma (NHL) with secondary cutaneous involvement, which may have a completely different clinical behavior and prognosis. In this article, we have summarized the clinico-pathological features of main types of PCBCL and we outline the guidelines for management based on a review of the available literature.

AB - The term 'Primary Cutaneous B-Cell Lymphoma' (PCBCL) comprehends a variety of lymphoproliferative disorders characterized by a clonal proliferation of B-cells primarily involving the skin. The absence of evident extra-cutaneous disease must be confirmed after six-month follow-up in order to exclude a nodal non-Hodgkin's lymphoma (NHL) with secondary cutaneous involvement, which may have a completely different clinical behavior and prognosis. In this article, we have summarized the clinico-pathological features of main types of PCBCL and we outline the guidelines for management based on a review of the available literature.

KW - Cutaneous B-cell lymphoma

KW - Primary Cutaneous Diffuse Large B cell Lymphoma other

KW - Primary cutaneous diffuse large B-cell lymphoma leg type

KW - Primary cutaneous follicle-center lymphoma

KW - Primary Cutaneous Marginal zone Lymphoma

UR - http://www.scopus.com/inward/record.url?scp=85015344646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015344646&partnerID=8YFLogxK

U2 - 10.4103/ijd.IJD_74_17

DO - 10.4103/ijd.IJD_74_17

M3 - Article

AN - SCOPUS:85015344646

VL - 62

SP - 146

EP - 157

JO - Indian Journal of Dermatology

JF - Indian Journal of Dermatology

SN - 0019-5154

IS - 2

ER -

A literature revision in primary cutaneous B-cell lymphoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this